Safely slowing down the decline in Alzheimer’s disease: gene therapy shows potential

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.7, 2005-07, pp. : 913-915

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene identification in Alzheimer’s disease

By Saunders Ann M

Pharmacogenomics, Vol. 2, Iss. 3, 2001-08 ,pp. : 239-249

Future Medicine

Access to resources Recommend Favorite

Slowing progression in Alzheimer's disease: potential of `Cerebrolysin'

Inpharma, Vol. 1, Iss. 1265, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

The presenilins as potential drug targets in Alzheimer’s disease

By Cupers P. Annaert W.G. Strooper B.D.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 413-422

Informa Healthcare

Access to resources Recommend Favorite

Potential therapeutic targets for Alzheimer’s disease

By McKeon-O’Malley C. Saunders A.J. Bush A.I. Tanzi R.E.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 157-179

Informa Healthcare

Access to resources Recommend Favorite

New concepts in the drug therapy of Alzheimer’s disease

By Farlow Martin R Hake Ann Marie

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 1975-1983

Informa Healthcare

Access to resources Recommend Favorite